This company is at the forefront of digital therapeutics
focusing on Alzheimer's and neurodegenerative diseases .
Through memory stimulation and displaying photographs of the
patients past life , the patient is stimulated and memory
improves markedly. Dethera's pilot program has been
initially positive and results have been very encouraging .
With a superior management team in placeTEAM
we feel these shares merit investor attention and following
.
We place these shares on ourStrong
Buylist
with our initial coverage -
GET REPORT
subsidiary
of Target Publishing Inc, and is a leading publisher of
todays market and investment news, commentary,
proprietary research and videos from seasoned
journalists, analysts and contributors covering the
financial markets and global economies. Leveraging our
extensive distribution network and social media
presence, we havecultivated
a valuable audieXnceof
engaged market enthusiasts, which in turn
delivers a variety of unique opportunities for industry
partnerships, corporate communications, market exposure
and investment. We
are paid cash compensation by the company only for the distribution of this report.